Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma

Galactose-modified selenium nanoparticles (GA-SeNPs) loading with doxorubicin (DOX) for hepatocellular carcinoma (HCC) therapy was investigated in this paper. Selenium nanoparticles (SeNPs) were modified with galactose as tumor targeting moiety to fabricate tumor-targeted delivery carrier GA-SeNPs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yu, Zhong, Jiayu, Zhao, Mingqi, Tang, Ying, Han, Ning, Hua, Liang, Xu, Tiantian, Wang, Changbing, Zhu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327939/
https://www.ncbi.nlm.nih.gov/pubmed/31928356
http://dx.doi.org/10.1080/10717544.2018.1556359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327939/
https://www.ncbi.nlm.nih.gov/pubmed/31928356
http://dx.doi.org/10.1080/10717544.2018.1556359

Ejemplares similares